Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,496
Total Claims
$938K
Drug Cost
470
Beneficiaries
$1,996
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+53%
Opioid rate vs peers
3.4% vs 2.2% avg
+41%
Cost per patient vs peers
$1,996 vs $1,411 avg
+41%
Brand preference vs peers
15.0% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.4%
Opioid Rate
257
Opioid Claims
$6,366
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,110 claims · $804K
Generic: 6,291 claims · $130K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 107 | $129K |
| Tirzepatide | 74 | $94K |
| Dulaglutide | 61 | $69K |
| Sitagliptin Phosphate | 47 | $57K |
| Dapagliflozin Propanediol | 45 | $40K |
| Apixaban | 38 | $33K |
| Empagliflozin | 36 | $31K |
| Insulin Glargine,hum.Rec.Anlog | 33 | $30K |
| Fluticasone/Umeclidin/Vilanter | 32 | $27K |
| Semaglutide | 20 | $23K |
| Insulin Degludec | 37 | $21K |
| Insulin Glargine/Lixisenatide | 28 | $21K |
| Budesonide/Formoterol Fumarate | 31 | $20K |
| Sitagliptin Phos/Metformin Hcl | 11 | $16K |
| Mirabegron | 20 | $15K |
Prescribing Profile
Patient Profile
72
Avg Age
63%
Female
1.21
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About